Over the forecast period, a rise in the use of inorganic growth techniques, such as key companies working together to develop paediatric antibiotics, is anticipated to fuel the expansion of the worldwide paediatric antibiotics market. For instance, in April 2020, the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit research and development (R&D) organisation, and Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company, announced a collaboration to quicken the development of and access to cefepime-taniborbactam (previously known as cefepime/VNRX-5133). Cefepime-taniborbactam is a novel, broad-spectrum beta-lactamase inhibitor that restores the activity of cefepime against carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA). It is an investigational combination of the fourth-generation antibiotic cefepime. To finish the complex urinary tract infection (cUTI) phase 3 trial for cefepime-taniborbactam, GARDP will work with Venatorx.
The market for Paediatric Antibiotics is anticipated to reach a value of US$6,478.9 million in 2022 and is predicted to grow at a CAGR of 2.3% from 2022 to 2030.
Prominent Companies in the Pediatric Antibiotics Industry:
1. Johnson & Johnson: Johnson & Johnson Development - JJDC - was a venture capital fund run by Johnson & Johnson Innovation. The fund is based in New Brunswick, New Jersey, and it makes investments in the United States. It focused on healthcare devices and supplies, pharmaceuticals and biotechnology, and life science. The company was founded in 1978. In 1978, the headquarters were established. Johnson & Johnson's Janssen Pharmaceutical Companies announced in 2020 that it will expand its existing collaboration with the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, to seek treatment solutions for COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.
2. Pfizer Inc.: Built in 1848. One of the biggest pharmaceutical companies in the world, Pfizer with yearly sales of around $50 billion (excluding COVID-19 product sales). The company used to sell a wide variety of chemicals and healthcare items, but today the majority of its sales come from prescription medications and vaccinations. United States headquarters. Today, Truveta and Pfizer established a collaborative partnership to give ongoing safety insights based on scalable, verified real-world data.
3. Novartis AG: Innovative Medicines and Sandoz are two business sectors under which Novartis develops and produces healthcare goods. company Innovative pharmaceuticals sector, which includes international business franchises in oncology, ophthalmology, neurology, immunology, respiratory, cardio-metabolic, and established pharmaceuticals, accounts for the vast bulk of company revenue. Founded in 1996. Novartis successfully acquires The Medicines Company, adding the investigational cholesterol-lowering drug inclisiran, which may be a first-in-class treatment.
4.Bristol-Myers Squibb Company: Bristol-Myers Squibb discovers, develops, and markets pharmaceuticals for a wide range of therapeutic areas, including cardiovascular, cancer, and immunological illnesses. Bristol has a strong concentration on immuno-oncology, where it is a market leader in medication development. Founded 1887. Headquarters are in New York, USA. Bristol Myers Squibb was the ideal partner, bringing the best transaction structure, significant expertise, and a commitment of resources.
5. Dr. Reddy’s Laboratories Ltd: Dr. Reddy's Laboratories is an Indian company with global operations that develops and produces generic pharmaceuticals. The business specialises in active pharmaceutical ingredients and low-cost, easily manufactured small-molecule generic medications. Headquarters in Established in 1984.
Definition: Antibiotics are medicines that fight infections caused by bacteria in humans and animals by either killing the bacteria or making it difficult for the bacteria to grow and multiply.
